Immunoprotective effect of IM-133

International Journal of Immunopharmacology

Volumn 21, Issue 2, 1999, Pages 115-120

  Mitra, S K ^a   Gupta, M ^a   Suryanarayana, T ^a   Sarma, D N K ^a  

^a Himalaya Health Care   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; IM 133; IMMUNOMODULATING AGENT; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; IMMUNOMODULATION; MALE; MORTALITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; FEMALE; MALE; MEDICINE, AYURVEDIC; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PHAGOCYTOSIS; PHYTOTHERAPY;

EID: 0032990752     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00071-X     Document Type: Article

References (12)

1. H2 hypothesis of HIV infection: new insights. Immunol. Today, 15, 575-581.
2. Ding, A. H., Nathan, C. F., & Stuehr, D. J. (1988). Release of reactive nitrogen intermediates from mouse peritoneal macrophages. Comparision of activating cytokines and evidence for independent production. J. Immunol., 141, 2407-2412.
3. Glauser, M. P., Heumann, D., Baumgartner, J. D., & Cohen, J. (1994). Pathogenesis and potential strategies for prevention and treatment of septic shock: An update. Clin. Inf. Dis., 18 (2), S205-216.
4. Godhwani, S., Godhwani, J. L., & Vyas, D. S. (1988). Ocimum sanctum - a preliminary study evaluating its immunoregulatory profile in albino rats. J. Ethnopharmacol., 24, 193-198.
5. Hadden, J. W. (1982). Immunomodulators in the immunotherapy of cancer and other diseases. Trends Pharmacol. Sci., 3, 191-194.
6. Kaufmann, S. H. E. (1995). Immunity to intracellular pathogens. Immunol. Today, 16, 338-342.
7. H2 cytokines. Eur. J. Immunol., 25, 1101-1104.
8. Singh, R. H. (1978). Rejuvenation Therapy. In K. N. Udupa, R. H. Singh, (Eds.), Science and philosophy of Indian Medicine. Nagpur, India: Shree Baidyanath Ayurved Bhavan, (pp. 128-138).
9. Suresh, K., & Vasudevan, D. M. (1994). Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator. J. Ethnopharmacol., 44, 55-60.
10. Thatte, U. M., & Dahanukar, S. A. (1989). Immunotherapeutic modification of experimental infections by Indian medicinal plants. Phytother. Res., 3 (2), 43-49.
11. Uma Devi, P. (1996). Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Indian J. Exp. Biol., 34, 927-932.
12. Uma Devi, P., Sharada, A. C., & Solomon, F. E. (1993). Antitumor and radiosensitizing effects of Withania somnifera (Ashwagandha) on transplantable mouse tumor, Sarcoma-180. Indian J. Exp. Biol., 31, 607-611.